Trade Mark Journal No.2026/030 24 July 2026

UK00004416363 15 July 2026 (5)

ANVERIX

Class 5
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD).

Ridge Pharma Limited

Representative: Reddie & Grose LLP